Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.
There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.
This report aims to provide a comprehensive presentation of the global market for Human Rabies Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rabies Vaccines. This report contains market size and forecasts of Human Rabies Vaccines in global, including the following market information:
Global Human Rabies Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Human Rabies Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Human Rabies Vaccines companies in 2022 (%)
The global Human Rabies Vaccines market was valued at US$ 1086.6 million in 2022 and is projected to reach US$ 1370.3 million by 2029, at a CAGR of 3.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share.
Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.
The classification of Human Rabies Vaccine includes Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, and Others. In addition, the proportion of Vero Cell rabies vaccines is about 85%.
Human Rabies Vaccine is widely used for Pre-exposure and Post-exposure. The segment of Human Rabies Vaccine used for Post-exposure and the market share is over 70% of the share.
We surveyed the Human Rabies Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Rabies Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Rabies Vaccines Market Segment Percentages, by Type, 2022 (%)
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others
Global Human Rabies Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Rabies Vaccines Market Segment Percentages, by Application, 2022 (%)
Pre-Exposure Prophylaxis
Post-Exposure Prophylaxis
Global Human Rabies Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Rabies Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Rabies Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Human Rabies Vaccines revenues share in global market, 2022 (%)
Key companies Human Rabies Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Human Rabies Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi Pasteur?Inc.
Novartis Vaccines and Diagnostics Ltd.
Cadila Pharmaceuticals Ltd.
GlaxoSmithKline Biologicals
Merck?Co Inc.
Wyeth pharmaceuticals
Berna Biotech Ltd.
Medimmune LLC
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Rabies Vaccines, market overview.
Chapter 2: Global Human Rabies Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Human Rabies Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Rabies Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Rabies Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Human Rabies Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Rabies Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Rabies Vaccines Overall Market Size
2.1 Global Human Rabies Vaccines Market Size: 2022 VS 2029
2.2 Global Human Rabies Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Human Rabies Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Human Rabies Vaccines Players in Global Market
3.2 Top Global Human Rabies Vaccines Companies Ranked by Revenue
3.3 Global Human Rabies Vaccines Revenue by Companies
3.4 Global Human Rabies Vaccines Sales by Companies
3.5 Global Human Rabies Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Human Rabies Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Rabies Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Rabies Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Human Rabies Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Rabies Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Rabies Vaccines Market Size Markets, 2022 & 2029
4.1.2 Vero Cell Rabies Vaccine
4.1.3 BHK
4.1.4 Chick Embryo Cell Rabies Vaccine
4.1.5 Others
4.2 By Type - Global Human Rabies Vaccines Revenue & Forecasts
4.2.1 By Type - Global Human Rabies Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Human Rabies Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Human Rabies Vaccines Revenue Market Share, 2018-2029
4.3 By Type - Global Human Rabies Vaccines Sales & Forecasts
4.3.1 By Type - Global Human Rabies Vaccines Sales, 2018-2023
4.3.2 By Type - Global Human Rabies Vaccines Sales, 2024-2029
4.3.3 By Type - Global Human Rabies Vaccines Sales Market Share, 2018-2029
4.4 By Type - Global Human Rabies Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Rabies Vaccines Market Size, 2022 & 2029
5.1.2 Pre-Exposure Prophylaxis
5.1.3 Post-Exposure Prophylaxis
5.2 By Application - Global Human Rabies Vaccines Revenue & Forecasts
5.2.1 By Application - Global Human Rabies Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Human Rabies Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Human Rabies Vaccines Revenue Market Share, 2018-2029
5.3 By Application - Global Human Rabies Vaccines Sales & Forecasts
5.3.1 By Application - Global Human Rabies Vaccines Sales, 2018-2023
5.3.2 By Application - Global Human Rabies Vaccines Sales, 2024-2029
5.3.3 By Application - Global Human Rabies Vaccines Sales Market Share, 2018-2029
5.4 By Application - Global Human Rabies Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Human Rabies Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Human Rabies Vaccines Revenue & Forecasts
6.2.1 By Region - Global Human Rabies Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Human Rabies Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Human Rabies Vaccines Revenue Market Share, 2018-2029
6.3 By Region - Global Human Rabies Vaccines Sales & Forecasts
6.3.1 By Region - Global Human Rabies Vaccines Sales, 2018-2023
6.3.2 By Region - Global Human Rabies Vaccines Sales, 2024-2029
6.3.3 By Region - Global Human Rabies Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Human Rabies Vaccines Revenue, 2018-2029
6.4.2 By Country - North America Human Rabies Vaccines Sales, 2018-2029
6.4.3 US Human Rabies Vaccines Market Size, 2018-2029
6.4.4 Canada Human Rabies Vaccines Market Size, 2018-2029
6.4.5 Mexico Human Rabies Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Human Rabies Vaccines Revenue, 2018-2029
6.5.2 By Country - Europe Human Rabies Vaccines Sales, 2018-2029
6.5.3 Germany Human Rabies Vaccines Market Size, 2018-2029
6.5.4 France Human Rabies Vaccines Market Size, 2018-2029
6.5.5 U.K. Human Rabies Vaccines Market Size, 2018-2029
6.5.6 Italy Human Rabies Vaccines Market Size, 2018-2029
6.5.7 Russia Human Rabies Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Human Rabies Vaccines Market Size, 2018-2029
6.5.9 Benelux Human Rabies Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Human Rabies Vaccines Revenue, 2018-2029
6.6.2 By Region - Asia Human Rabies Vaccines Sales, 2018-2029
6.6.3 China Human Rabies Vaccines Market Size, 2018-2029
6.6.4 Japan Human Rabies Vaccines Market Size, 2018-2029
6.6.5 South Korea Human Rabies Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Human Rabies Vaccines Market Size, 2018-2029
6.6.7 India Human Rabies Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Human Rabies Vaccines Revenue, 2018-2029
6.7.2 By Country - South America Human Rabies Vaccines Sales, 2018-2029
6.7.3 Brazil Human Rabies Vaccines Market Size, 2018-2029
6.7.4 Argentina Human Rabies Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Rabies Vaccines Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Human Rabies Vaccines Sales, 2018-2029
6.8.3 Turkey Human Rabies Vaccines Market Size, 2018-2029
6.8.4 Israel Human Rabies Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Human Rabies Vaccines Market Size, 2018-2029
6.8.6 UAE Human Rabies Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi Pasteur?Inc.
7.1.1 Sanofi Pasteur?Inc. Company Summary
7.1.2 Sanofi Pasteur?Inc. Business Overview
7.1.3 Sanofi Pasteur?Inc. Human Rabies Vaccines Major Product Offerings
7.1.4 Sanofi Pasteur?Inc. Human Rabies Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Pasteur?Inc. Key News & Latest Developments
7.2 Novartis Vaccines and Diagnostics Ltd.
7.2.1 Novartis Vaccines and Diagnostics Ltd. Company Summary
7.2.2 Novartis Vaccines and Diagnostics Ltd. Business Overview
7.2.3 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Major Product Offerings
7.2.4 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Novartis Vaccines and Diagnostics Ltd. Key News & Latest Developments
7.3 Cadila Pharmaceuticals Ltd.
7.3.1 Cadila Pharmaceuticals Ltd. Company Summary
7.3.2 Cadila Pharmaceuticals Ltd. Business Overview
7.3.3 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Major Product Offerings
7.3.4 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Cadila Pharmaceuticals Ltd. Key News & Latest Developments
7.4 GlaxoSmithKline Biologicals
7.4.1 GlaxoSmithKline Biologicals Company Summary
7.4.2 GlaxoSmithKline Biologicals Business Overview
7.4.3 GlaxoSmithKline Biologicals Human Rabies Vaccines Major Product Offerings
7.4.4 GlaxoSmithKline Biologicals Human Rabies Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 GlaxoSmithKline Biologicals Key News & Latest Developments
7.5 Merck?Co Inc.
7.5.1 Merck?Co Inc. Company Summary
7.5.2 Merck?Co Inc. Business Overview
7.5.3 Merck?Co Inc. Human Rabies Vaccines Major Product Offerings
7.5.4 Merck?Co Inc. Human Rabies Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Merck?Co Inc. Key News & Latest Developments
7.6 Wyeth pharmaceuticals
7.6.1 Wyeth pharmaceuticals Company Summary
7.6.2 Wyeth pharmaceuticals Business Overview
7.6.3 Wyeth pharmaceuticals Human Rabies Vaccines Major Product Offerings
7.6.4 Wyeth pharmaceuticals Human Rabies Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 Wyeth pharmaceuticals Key News & Latest Developments
7.7 Berna Biotech Ltd.
7.7.1 Berna Biotech Ltd. Company Summary
7.7.2 Berna Biotech Ltd. Business Overview
7.7.3 Berna Biotech Ltd. Human Rabies Vaccines Major Product Offerings
7.7.4 Berna Biotech Ltd. Human Rabies Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Berna Biotech Ltd. Key News & Latest Developments
7.8 Medimmune LLC
7.8.1 Medimmune LLC Company Summary
7.8.2 Medimmune LLC Business Overview
7.8.3 Medimmune LLC Human Rabies Vaccines Major Product Offerings
7.8.4 Medimmune LLC Human Rabies Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Medimmune LLC Key News & Latest Developments
8 Global Human Rabies Vaccines Production Capacity, Analysis
8.1 Global Human Rabies Vaccines Production Capacity, 2018-2029
8.2 Human Rabies Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Rabies Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Rabies Vaccines Supply Chain Analysis
10.1 Human Rabies Vaccines Industry Value Chain
10.2 Human Rabies Vaccines Upstream Market
10.3 Human Rabies Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Rabies Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Human Rabies Vaccines in Global Market
Table 2. Top Human Rabies Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Human Rabies Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Human Rabies Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Human Rabies Vaccines Sales by Companies, (K Units), 2018-2023
Table 6. Global Human Rabies Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Human Rabies Vaccines Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Human Rabies Vaccines Product Type
Table 9. List of Global Tier 1 Human Rabies Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Rabies Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Human Rabies Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Human Rabies Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Human Rabies Vaccines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Human Rabies Vaccines Sales (K Units), 2018-2023
Table 15. By Type - Global Human Rabies Vaccines Sales (K Units), 2024-2029
Table 16. By Application ? Global Human Rabies Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Human Rabies Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Human Rabies Vaccines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Human Rabies Vaccines Sales (K Units), 2018-2023
Table 20. By Application - Global Human Rabies Vaccines Sales (K Units), 2024-2029
Table 21. By Region ? Global Human Rabies Vaccines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Human Rabies Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Human Rabies Vaccines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Human Rabies Vaccines Sales (K Units), 2018-2023
Table 25. By Region - Global Human Rabies Vaccines Sales (K Units), 2024-2029
Table 26. By Country - North America Human Rabies Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Human Rabies Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Human Rabies Vaccines Sales, (K Units), 2018-2023
Table 29. By Country - North America Human Rabies Vaccines Sales, (K Units), 2024-2029
Table 30. By Country - Europe Human Rabies Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Human Rabies Vaccines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Human Rabies Vaccines Sales, (K Units), 2018-2023
Table 33. By Country - Europe Human Rabies Vaccines Sales, (K Units), 2024-2029
Table 34. By Region - Asia Human Rabies Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Human Rabies Vaccines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Human Rabies Vaccines Sales, (K Units), 2018-2023
Table 37. By Region - Asia Human Rabies Vaccines Sales, (K Units), 2024-2029
Table 38. By Country - South America Human Rabies Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Human Rabies Vaccines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Human Rabies Vaccines Sales, (K Units), 2018-2023
Table 41. By Country - South America Human Rabies Vaccines Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Human Rabies Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Human Rabies Vaccines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Human Rabies Vaccines Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Human Rabies Vaccines Sales, (K Units), 2024-2029
Table 46. Sanofi Pasteur?Inc. Company Summary
Table 47. Sanofi Pasteur?Inc. Human Rabies Vaccines Product Offerings
Table 48. Sanofi Pasteur?Inc. Human Rabies Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Sanofi Pasteur?Inc. Key News & Latest Developments
Table 50. Novartis Vaccines and Diagnostics Ltd. Company Summary
Table 51. Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Product Offerings
Table 52. Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Novartis Vaccines and Diagnostics Ltd. Key News & Latest Developments
Table 54. Cadila Pharmaceuticals Ltd. Company Summary
Table 55. Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Product Offerings
Table 56. Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Cadila Pharmaceuticals Ltd. Key News & Latest Developments
Table 58. GlaxoSmithKline Biologicals Company Summary
Table 59. GlaxoSmithKline Biologicals Human Rabies Vaccines Product Offerings
Table 60. GlaxoSmithKline Biologicals Human Rabies Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. GlaxoSmithKline Biologicals Key News & Latest Developments
Table 62. Merck?Co Inc. Company Summary
Table 63. Merck?Co Inc. Human Rabies Vaccines Product Offerings
Table 64. Merck?Co Inc. Human Rabies Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Merck?Co Inc. Key News & Latest Developments
Table 66. Wyeth pharmaceuticals Company Summary
Table 67. Wyeth pharmaceuticals Human Rabies Vaccines Product Offerings
Table 68. Wyeth pharmaceuticals Human Rabies Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Wyeth pharmaceuticals Key News & Latest Developments
Table 70. Berna Biotech Ltd. Company Summary
Table 71. Berna Biotech Ltd. Human Rabies Vaccines Product Offerings
Table 72. Berna Biotech Ltd. Human Rabies Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Berna Biotech Ltd. Key News & Latest Developments
Table 74. Medimmune LLC Company Summary
Table 75. Medimmune LLC Human Rabies Vaccines Product Offerings
Table 76. Medimmune LLC Human Rabies Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Medimmune LLC Key News & Latest Developments
Table 78. Human Rabies Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 79. Global Human Rabies Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Human Rabies Vaccines Production by Region, 2018-2023 (K Units)
Table 81. Global Human Rabies Vaccines Production by Region, 2024-2029 (K Units)
Table 82. Human Rabies Vaccines Market Opportunities & Trends in Global Market
Table 83. Human Rabies Vaccines Market Drivers in Global Market
Table 84. Human Rabies Vaccines Market Restraints in Global Market
Table 85. Human Rabies Vaccines Raw Materials
Table 86. Human Rabies Vaccines Raw Materials Suppliers in Global Market
Table 87. Typical Human Rabies Vaccines Downstream
Table 88. Human Rabies Vaccines Downstream Clients in Global Market
Table 89. Human Rabies Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Human Rabies Vaccines Segment by Type in 2022
Figure 2. Human Rabies Vaccines Segment by Application in 2022
Figure 3. Global Human Rabies Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Rabies Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Human Rabies Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. Human Rabies Vaccines Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Human Rabies Vaccines Revenue in 2022
Figure 9. By Type - Global Human Rabies Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Human Rabies Vaccines Revenue Market Share, 2018-2029
Figure 11. By Type - Global Human Rabies Vaccines Sales Market Share, 2018-2029
Figure 12. By Type - Global Human Rabies Vaccines Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Human Rabies Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Human Rabies Vaccines Revenue Market Share, 2018-2029
Figure 15. By Application - Global Human Rabies Vaccines Sales Market Share, 2018-2029
Figure 16. By Application - Global Human Rabies Vaccines Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Human Rabies Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Human Rabies Vaccines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Human Rabies Vaccines Revenue Market Share, 2018-2029
Figure 20. By Region - Global Human Rabies Vaccines Sales Market Share, 2018-2029
Figure 21. By Country - North America Human Rabies Vaccines Revenue Market Share, 2018-2029
Figure 22. By Country - North America Human Rabies Vaccines Sales Market Share, 2018-2029
Figure 23. US Human Rabies Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Human Rabies Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Human Rabies Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Human Rabies Vaccines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Human Rabies Vaccines Sales Market Share, 2018-2029
Figure 28. Germany Human Rabies Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. France Human Rabies Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Human Rabies Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Human Rabies Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Human Rabies Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Human Rabies Vaccines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Human Rabies Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Human Rabies Vaccines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Human Rabies Vaccines Sales Market Share, 2018-2029
Figure 37. China Human Rabies Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Human Rabies Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Human Rabies Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Human Rabies Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. India Human Rabies Vaccines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Human Rabies Vaccines Revenue Market Share, 2018-2029
Figure 43. By Country - South America Human Rabies Vaccines Sales Market Share, 2018-2029
Figure 44. Brazil Human Rabies Vaccines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Human Rabies Vaccines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Human Rabies Vaccines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Human Rabies Vaccines Sales Market Share, 2018-2029
Figure 48. Turkey Human Rabies Vaccines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Human Rabies Vaccines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Human Rabies Vaccines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Human Rabies Vaccines Revenue, (US$, Mn), 2018-2029
Figure 52. Global Human Rabies Vaccines Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Human Rabies Vaccines by Region, 2022 VS 2029
Figure 54. Human Rabies Vaccines Industry Value Chain
Figure 55. Marketing Channels
